Taiwan · Delayed Price · Currency is TWD Orient EuroPharma Company Description
Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide.
Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs.
The company also provides nutrition and baby care products, such as milk and nutritional supplements under the Karihome, Babecare, and Ostricare brands; and healthcare supplements, such as thermal water for the treatment of oral and periodontal diseases under the Buccotherm name.
In addition, the company offers essences, creams, lotions, eye creams, facial treatment toners, and skin repairing essences under the AGLab name; skincare oils, body lotions, and dry skin gels under the Bio-Oil name; and children skincare products under the Mister Baby brand, as well as operates ISISPHARMA, a dermatology laboratory specialized in the development and distribution of dermo-cosmetic products.
Further, it engages in the research and development of Multikine, an immunotherapy drug for head and neck cancer, which is in Phase III clinical study; NC-6004, a platinum-based micelle chemotherapeutic drug that is in Phase III clinical study; ASC-J9, a molecular chemical entity drug that has completed Phase IIb clinical study for androgen receptor degradation; and 2ccPA, a derivative of phospholipid to patients with symptomatic osteoarthritis of the knee, which is in Phase I clinical trail.
Orient EuroPharma Co., Ltd. was founded in 1982 and is based in Taipei, Taiwan.
| Country | Taiwan |
| Founded | 1982 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 339 |
| CEO | Peter Tsai |
Contact Details
Address: No. 128, Chengde Road Taipei, 112 Taiwan | |
| Phone | 886 2 2755 4881 |
| Website | oepgroup.com |
Stock Details
| Ticker Symbol | 4120 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004120001 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Peter Tsai | Chairman, Chief Executive Officer and President |
| Jack Wang | Financial Officer and Accounting Officer |
| Liann Lai | Director of Human Resources and Administrative Division |
| Jack Wu | Director |